Our Faculty
Jose C. Florez, MD, PhD
Jose Florez and his group have contributed to the performance and analysis of high-throughput genomic studies in type 2 diabetes, related traits and complications, in international consortia such as MAGIC, GENIE, DIAGRAM, T2D-GENES, AMP-T2D and SIGMA. He leads the genetic research initiative of the Diabetes Prevention Program, and is the PI of the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) and other pharmacogenetic studies at MGH.
Questions being addressed in the lab
Projects underway to answer these questions
Answers Found
Genetic determinants of type 2 diabetes to date, by year of publication, effect size and mode of discovery
-
Human glycemic response to a glipizide challenge by genotype at a type 2 diabetes-associated variant in TCF7L2
-
Intensive lifestyle modification abolishes the risk of type 2 diabetes conferred by genetic variants
-
Highlighted Publications from the lab
Analysis of protein-coding genetic variation in 60,706 humans
August, 2016
The genetic architecture of type 2 diabetes
August, 2016